Men ≥ 40 years of age attending Duke Health/Urology with suspicion of prostate cancer (Primary disease) will be approached to consent for the study. Upon consent, samples will be obtained alone, during repeat PSA/other biomarkers testing, or during imaging at Duke Lab.
You may not be if
Men who have previously undergone treatment for prostate cancer.
Men with prior diagnosis of prostate cancer.
Men with severe, irreversible coagulopathy.
Men on anticoagulant therapies or those who have taken antiplatelet agents such as aspirin, NSAIDs (ibuprofen, entrophen, naproxen, diclofenac etc), clopidrogel, prasugrel, ticagrelor, or dipyridamole in the 7 days preceding blood collection.
Clareo Health | Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
